Global Bone Cement Shortage Threatens NHS Surgery Delays for Thousands
NHS Surgery Delays Loom Due to Bone Cement Shortage

Global Bone Cement Shortage Threatens NHS Surgery Delays for Thousands

Experts have issued a stark warning that a severe global shortage of bone cement could further exacerbate the already lengthy waiting times for surgery within the National Health Service. This critical supply chain issue poses a significant threat to the scheduling of thousands of pre-planned operations, particularly hip and knee replacements.

Immediate Impact on Orthopaedic Procedures

The shortage stems from a packaging fault reported by Heraeus Medical, the NHS's primary supplier of bone cement. This fault has temporarily halted production at their main facility, with product availability expected to be impacted for a minimum of two months. Bone cement is essential for anchoring artificial joints, as it fills the space between the new implant and the patient's natural bone.

In response, NHS England has issued immediate guidance to hospitals across the country. This directive instructs trusts to prioritise trauma and urgent care cases using existing stock, while also exploring the use of alternative suppliers where feasible. Officials estimate that while the NHS currently has supply for approximately the next two weeks, a potential gap of six to eight weeks in availability could follow.

A "Crushing Blow" for Patients

Campaigners have described the situation as a "crushing blow" for patients who have already endured prolonged waits for surgery. Deborah Alsina, chief executive of Arthritis UK, emphasised the personal toll, stating, "This is a crushing blow for those individuals who have finally made it to the front of the orthopaedic surgery queue after a long time waiting."

She urged the Department of Health and Social Care to address the supply issues swiftly, noting the high stakes for the Government in meeting its ambitious targets to reduce waiting lists. Tens of thousands of patients undergo hip or knee replacements in England annually, making this shortage a matter of significant public health concern.

Coordinated Response and Alternative Measures

An NHS England spokesperson confirmed that any stock already within hospitals remains unaffected. The health service is collaborating closely with Government departments and leading professional bodies to ensure safe and effective care can be maintained while the supply issue is resolved.

Fergal Monsell, president of the British Orthopaedic Association (BOA), outlined the coordinated response. "The BOA is working with NHS officials to identify possible alternative supplies to reduce the impact on patients," he said. He acknowledged that the situation is beyond the control of surgeons and NHS organisations, with recommended solutions focused on patient safety and clinical need.

To mitigate delays, NHS trusts have been advised to utilise any released theatre time to treat orthopaedic patients whose procedures do not require the use of cement. The BOA has committed to updating surgeons regularly as the situation develops.

Support for Affected Individuals

Arthritis UK has called for hospitals to communicate quickly with affected patients to prevent additional anxiety and uncertainty. The charity is offering support through its free helpline and online community, providing information and advice to those awaiting surgery.

This bone cement shortage highlights the vulnerabilities within global medical supply chains and their direct impact on national healthcare systems. The coming weeks will be critical as the NHS navigates this challenge, striving to minimise delays for the thousands of patients whose lives and wellbeing depend on timely surgical intervention.